RecruitingNCT06908616

Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates

The Prevalence of Ethnic Neutropenia in Neonates


Sponsor

Kaplan Medical Center

Enrollment

1,000 participants

Start Date

Oct 8, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be collected to correlate phenotype with absolute neutrophil count (ANC).


Eligibility

Min Age: 1 MinuteMax Age: 1 Day

Inclusion Criteria3

  • Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025
  • Parental informed consent obtained
  • Umbilical cord blood available for routine testing

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCord blood

Cord blood samples will be collected during routine G6PD testing. An additional 3 mL will be obtained non-invasively from the umbilical cord to determine the expression of Duffy antigens using serologic gel testing.


Locations(1)

Kaplan Medical Center

Rehovot, Israel, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06908616


Related Trials